Numerous studies support the beneficial effects of dermatological drugs on AD by modulating inflammatory and infectious responses, reducing Aβ and tau accumulation, and inhibiting neurodegeneration (Table 3). This evidence concerns the gene MAPT and Alzheimer disease.